Navamedic
Less than 1K followers
NAVA
Oslo Børs
Biotechnology & Pharmaceuticals
Health Care
Overview
Investor consensus
Navamedic is a Nordic pharmaceutical company that supplies pharmaceuticals, OTC, medical nutrition products for rare diagnoses and medical devices to hospitals and pharmacies in areas such as obesity, women's health, urology, gastrointestinal and pain. Navamedic operates in the Nordic countries, the Baltics and Benelux but is also represented in the UK and Greece. The company was established in 1999 and is headquartered in Oslo.
Read moreMarket cap
-
Turnover
-
Revenue
531.44M
EBIT %
4.54 %
P/E
-
Dividend yield-%
-
Financial calendar
7.1
2026
Extraordinary general meeting '26
12.2
2026
Annual report '25
All
Press releases
3rd party
ShowingAll content types
Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026
Oslo, December 9, 2025 - Navamedic ASA Introduces Flexilev[®] in OraFID[®]: Enhancing Parkinson's Care with Simplified and Precise Dosing for Personalized Treatment
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools